Literature DB >> 17982654

The 2,6-disubstituted purine reversine induces growth arrest and polyploidy in human cancer cells.

Tze-Chen Hsieh1, Frank Traganos, Zbigniew Darzynkiewicz, Joseph M Wu.   

Abstract

Reversine (RV) is the synthetic purine identified from a protein kinase-based screen of purine mimetics and it has been shown to induce muscle myoblast differentiation into progenitor cells that can be further converted into other cell lineages. Since protein kinases play a pivotal role in cell cycle control, we hypothesize that RV might affect the proliferation of cancer cells. Herein we report that RV inhibited growth of cultured human tumor cells, respectively, PC-3, HeLa, CWR22Rv1, and DU-145 cells, and induced accumulation of polyploidal cells with > or =4N DNA content. However, RV was without effect on growth of normal prostate epithelial cells. RV-treated PC-3 cells showed enlarged nuclei and an estimated 100-fold increase in cell size. Moreover, PC-3 cells treated with RV for 2-4 days were accompanied by a marked increase in the expression of p21(WAF1), a modest elevation in the levels of cyclin D3 and CDK6 and concomitantly, also a substantial reduction in cyclin B and CDK1. These results suggest that RV may induce polyploidy and increase in cell size by up-regulating p21(WAF1) and cyclin D3/CDK6, while simultaneously suppressing the expression of cyclin B and CDK1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982654      PMCID: PMC2582159     

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  26 in total

1.  Nobel Lecture. Cyclin dependent kinases and cell cycle control.

Authors:  Paul M Nurse
Journal:  Biosci Rep       Date:  2002 Oct-Dec       Impact factor: 3.840

2.  Dedifferentiation of lineage-committed cells by a small molecule.

Authors:  Shuibing Chen; Qisheng Zhang; Xu Wu; Peter G Schultz; Sheng Ding
Journal:  J Am Chem Soc       Date:  2004-01-21       Impact factor: 15.419

Review 3.  From polyploidy to aneuploidy, genome instability and cancer.

Authors:  Zuzana Storchova; David Pellman
Journal:  Nat Rev Mol Cell Biol       Date:  2004-01       Impact factor: 94.444

Review 4.  Cell death by mitotic catastrophe: a molecular definition.

Authors:  Maria Castedo; Jean-Luc Perfettini; Thomas Roumier; Karine Andreau; Rene Medema; Guido Kroemer
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

5.  p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells.

Authors:  B D Chang; E V Broude; J Fang; T V Kalinichenko; R Abdryashitov; J C Poole; I B Roninson
Journal:  Oncogene       Date:  2000-04-20       Impact factor: 9.867

6.  Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells.

Authors:  C Lanzi; G Cassinelli; G Cuccuru; R Supino; V Zuco; C Ferlini; G Scambia; F Zunino
Journal:  Prostate       Date:  2001-09-15       Impact factor: 4.104

7.  Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line.

Authors:  K Nakano; T Mizuno; Y Sowa; T Orita; T Yoshino; Y Okuyama; T Fujita; N Ohtani-Fujita; Y Matsukawa; T Tokino; H Yamagishi; T Oka; H Nomura; T Sakai
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

8.  Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.

Authors:  B D Chang; K Watanabe; E V Broude; J Fang; J C Poole; T V Kalinichenko; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

9.  Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies.

Authors:  Tze-Chen Hsieh; Xiaohua Lu; Junqiao Guo; Wen Xiong; Jan Kunicki; Zbigniew Darzynkiewicz; Joseph M Wu
Journal:  Int J Oncol       Date:  2002-04       Impact factor: 5.650

10.  The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell line.

Authors:  Joo-Young Kim; Chul-Hwan Kim; Ian J Stratford; Adam V Patterson; Jolyon H Hendry
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-02-01       Impact factor: 7.038

View more
  15 in total

1.  Effect of reversine on cell cycle, apoptosis, and activation of hepatic stellate cells.

Authors:  Yu Huang; Di Huang; Jiefeng Weng; Shuai Zhang; Qiang Zhang; Zhenhao Mai; Weili Gu
Journal:  Mol Cell Biochem       Date:  2016-10-13       Impact factor: 3.396

2.  Reversine, a 2,6-disubstituted purine, as an anti-cancer agent in differentiated and undifferentiated thyroid cancer cells.

Authors:  Shih-Che Hua; Tien-Chun Chang; Hau-Ren Chen; Chieh-Hsiang Lu; Yi-Wen Liu; Shu-Hsin Chen; Hui-I Yu; Yi-Ping Chang; Ying-Ray Lee
Journal:  Pharm Res       Date:  2012-04-04       Impact factor: 4.200

3.  Reversine induces caspase-dependent apoptosis of human osteosarcoma cells through extrinsic and intrinsic apoptotic signaling pathways.

Authors:  Jae-Sung Kim; In-A Cho; Kyeong-Rok Kang; HyangI Lim; Tae-Hyeon Kim; Sun-Kyoung Yu; Heung-Joong Kim; Seul Ah Lee; Sung Min Moon; Hong Sung Chun; Chun Sung Kim; Do Kyung Kim
Journal:  Genes Genomics       Date:  2019-04-05       Impact factor: 1.839

4.  Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715.

Authors:  Roger B Slee; Brenda R Grimes; Ruchi Bansal; Jesse Gore; Corinne Blackburn; Lyndsey Brown; Rachel Gasaway; Jaesik Jeong; Jose Victorino; Keith L March; Riccardo Colombo; Brittney-Shea Herbert; Murray Korc
Journal:  Mol Cancer Ther       Date:  2013-11-26       Impact factor: 6.261

5.  Synergistic antitumor activity of reversine combined with aspirin in cervical carcinoma in vitro and in vivo.

Authors:  Hai-Xia Qin; Jun Yang; Hong-Kai Cui; Shao-Ping Li; Wei Zhang; Xiao-Li Ding; Yong-Hua Xia
Journal:  Cytotechnology       Date:  2013-03-10       Impact factor: 2.058

6.  Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy.

Authors:  Ying-Ray Lee; Wei-Ching Wu; Wen-Tsai Ji; Jeff Yi-Fu Chen; Ya-Ping Cheng; Ming-Ko Chiang; Hau-Ren Chen
Journal:  J Biomed Sci       Date:  2012-01-27       Impact factor: 8.410

7.  Reversine inhibits proliferation, invasion and migration and induces cell apoptosis in gastric cancer cells by downregulating TTK.

Authors:  Pengfei Xia; Jin Liang; Di Jin; Zhanyong Jin
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

8.  Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine.

Authors:  K Bijian; C Lougheed; J Su; B Xu; H Yu; J H Wu; K Riccio; M A Alaoui-Jamali
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

9.  Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays.

Authors:  Keyue Shen; Samantha Luk; Daniel F Hicks; Jessica S Elman; Stefan Bohr; Yoshiko Iwamoto; Ryan Murray; Kristen Pena; Fangjing Wang; Erkin Seker; Ralph Weissleder; Martin L Yarmush; Mehmet Toner; Dennis Sgroi; Biju Parekkadan
Journal:  Nat Commun       Date:  2014-12-09       Impact factor: 14.919

10.  Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells.

Authors:  Yin-Che Lu; Ying-Ray Lee; Ji-Der Liao; Ching-Yen Lin; Yih-Yuan Chen; Ping-Tzu Chen; Ya-Shih Tseng
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.